Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05988268
Other study ID # CBU-FTR-ES-O3
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 7, 2023
Est. completion date October 2, 2023

Study information

Verified date October 2023
Source Celal Bayar University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to compare the effects of 6-week vibration and non-vibration foam rolling on neuromuscular control and performance in male soccer players.


Description:

The typical warm-up protocol consists of different stretching exercises, sub-maximal aerobic activities, and sports-related activities. However, in recent years, warm-up protocols involving different methods have been applied and recommended. Foam rolling (FR) via foam roller, one of these methods, has become a common and popular method in many sports settings. While the popularity and use of the foam rolling method is gradually increasing, in recent years this method has begun to be applied as vibration and included in warming protocols. The aim of this study is to compare the effects of 6-week vibration and non-vibration foam rolling on neuromuscular control and performance in male soccer players. Within the scope of initial assessments; knee flexor and extensor muscle strength and Hamstring/Quadriceps muscle strength ratio with the Lafayette manual muscle testing device, flexibility with the sit-and-reach test, dynamic balance with the Y balance test, reaction time with the "Test You Brain Pro System", lower extremity anaerobic power with the Wingate anaerobic power test, agility with the t-test and sprint with the 20-m sprint test will be evaluated. After the initial assessment, vibration and non-vibration foam rolling methods will be applied to the gluteal, tensor fascia latae, hamstring, quadriceps femoris and gastrocnemius muscles of both lower extremities of the participants in the intervention groups, in addition to the routine warm-up protocol, 3 days a week for a total of 15 minutes a day for 6 weeks. No intervention will be applied to the participants in the control group. This group will continue the routine warm-up protocol. After the methods applied to the intervention groups for 6 weeks, the initial assessments applied to all participants will be repeated.


Recruitment information / eligibility

Status Completed
Enrollment 36
Est. completion date October 2, 2023
Est. primary completion date September 25, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 22 Years
Eligibility Inclusion Criteria: - Volunteering to participate in the study. - To regularly participate in team training within the club. - To have been playing football for at least 1 year in the category. Exclusion Criteria: - Having any sports injury involving the lower extremity and/or spine in the last 3 months. - Having a problem (vertigo, neuropathy, etc.) that may negatively affect balance and coordination. - Having a musculoskeletal deformity (short limb, etc.) concerning the lower and upper extremities. - Implementing a training program outside of routine team training

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Vibration Foam Rolling
The vibration foam rolling method will be applied to the gluteal, tensor fascia latae, hamstring, quadriceps femoris, and gastrocnemius muscles of both lower extremities of the participants in the Vibration Foam Rolling Group, in addition to the routine warm-up protocol, 3 days a week for a total of 15 minutes a day for 6 weeks.
Non-Vibration Foam Rolling
The non-vibration foam rolling method will be applied to the gluteal, tensor fascia latae, hamstring, quadriceps femoris, and gastrocnemius muscles of both lower extremities of the participants in the Non-Vibration Foam Rolling Group, in addition to the routine warm-up protocol, 3 days a week for a total of 15 minutes a day for 6 weeks.

Locations

Country Name City State
Turkey Izmir Katip Celebi University Izmir

Sponsors (2)

Lead Sponsor Collaborator
Celal Bayar University Izmir Katip Celebi University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Knee Flexor and Extensor Muscle Strength Participants' knee flexor and extensor muscle strength will be evaluated with the Lafayette manual muscle test device (Lafayette Instrument Company, Lafayette IN, USA).This device is a valid and reliable method that is frequently used in the evaluation of muscle strength.
During the evaluation, participants will be asked to perform a maximum isometric contraction for 3 seconds with the muscle in which the muscle strength is evaluated against the resistance to be applied with the manual muscle test device. Measurements will be repeated 3 times with one minute intervals for the right and left sides and the average of the measured values will be used for analysis.
A week
Primary Knee Flexor and Extensor Muscle Strength Ratio (H/Q Ratio) Participants' Hamstring/Quadriceps muscle strength ratio will be evaluated with the Lafayette manual muscle test device (Lafayette Instrument Company, Lafayette IN, USA). This device is a valid and reliable method that is frequently used in the evaluation of muscle strength. The Hamstring/Quadriceps muscle strength ratio will be determined by the ratio of the knee flexor and extensor muscle strengths obtained during the measurements. A week
Primary Flexibility The flexibility will be evaluated whit the sit-and-reach test. The testing box will be fixed to the wall, and participants will be requested to sit with their knees extended and the soles of their feet against the testing box. Then participants will be requested to slowly reach forward as far as possible along the top of the box and hold the position for 2 seconds without bending their knees. The average of the two trials will be used for analysis. A week
Secondary Dynamic Balance Dynamic balance will be evaluated with the Y balance test. The test is a valid and reliable method that was developed as a version of the Star Excursion Balance Test (SEBT) to improve repeatability and standardize the performance. During the preparation of the test, three tape measures; between the anterior and the posterolateral/posteromedial directions, will be fixed to the ground with 135° angles. The measurement will be done for the dominant side three times after the trial and the average of the endpoints where the athletes could reach will be used for analysis. The greater the distance the participants can reach during the test, the better participant's dynamic balance performance. A week
Secondary Agility Agility will be evaluated with the agility T-test. The test is a valid and reliable method used in the assessment of agility performance. For this test, an agility circuit will be created with 4 cones named 1, 2, 3, and 4. Cones will also set up at a distance of 10 yards between 1 and 2, and 5 yards between 2, and 3, 2, and 4. At the "go" command, the participant will sprint forward from cone 1 to cone 2, sidestepped to cone 3, sidestepped to cone 4, sidestepped to cone 2, then backpedal as fast as possible to cone 1. A stopwatch will be used during the test. The test will be performed 2 times with at least 2-minute rest periods between trials. The average of the 2 trials will be used for data analysis. A week
Secondary Sprint Sprint performance will be evaluated with the 20-m sprint test. The test is a valid and reliable method used in studies to evaluate sprint performance. During the test, at the "go" command, the participant will be asked to complete the 20-meter distance as quickly as possible, and a stopwatch will be used to determine the time to complete the test. All participants will performed the test 2 times with at least 2-minute rest periods between trials. The average of the 2 trials will be used for data analysis. A week
Secondary Reaction Time Lower-extremity V-MRT will be evaluated with the Test You Brain Pro System. This system is a method that consists of 6 semaphores (sensors), 6 stabilizers, 1 charging cable, and 1 tablet and assesses and trains the reaction time of individuals in many different environments. Before the assessments, 6 semaphores (light and sound stimuli) will be positioned to form a 180° semicircle, with each semaphore placed in increments of 45° around the semicircle.Participants will perform the test three times with 30-second intervals after one trial with their right lower-extremity, left lower-extremity, and right and left lower-extremities (random), respectively. The average of the scores obtained will be recorded and used for analysis. A week
Secondary Anaerobic Power Anaerobic power test will be evaluated with the electromagnetic ergometer (Ergomedic894E, Germany). The measurement method is to adjust and set the saddle height so that the knee of each participant could have a flexion of about 5°, and thus, 0.075 kp per unit weight will be supposed to be applied when reaching one's maximum speed. Afterward, a tester in synchronization with the computer verbally count a 5-second count down following warm-up and then verbally will give a "Start" signal, after which peak anaerobic power, average power, and fatigue index will be measured while encouraging participants to perform the exercise as much as possible for 30 seconds. A week
See also
  Status Clinical Trial Phase
Completed NCT05029518 - 3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability Phase 1
Completed NCT05001152 - Taste Assessment of Ozanimod Phase 1
Completed NCT04493255 - A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants Phase 1
Completed NCT03457649 - IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers Phase 1
Completed NCT00995891 - Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
Completed NCT05043766 - Evaluation of Oral PF614 Relative to OxyContin Phase 1
Completed NCT05050318 - Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively Phase 4
Completed NCT04466748 - A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects Phase 1
Completed NCT00746733 - Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC Phase 1
Recruiting NCT05929651 - Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy Phase 4
Completed NCT05954039 - Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect N/A
Completed NCT05045716 - A Study of Subcutaneous Lecanemab in Healthy Participants Phase 1
Active, not recruiting NCT02747927 - Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children Phase 3
Completed NCT05533801 - A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants Phase 1
Not yet recruiting NCT03931369 - Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST) Phase 2
Completed NCT03279146 - A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects Phase 1
Completed NCT06027437 - A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants Phase 1
Recruiting NCT05619874 - Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity N/A
Completed NCT05553418 - Investigational On-body Injector Clinical Study N/A
Completed NCT04092712 - Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers Phase 1